Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
May 10, 2024 at 02:00 AM EDT
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
